Auna S.A.
- Open
- 5.18
- Day high
- 5.32
- Day low
- 5.16
- Prev close
- 5.13
- Volume
- 113K
- Mkt cap
- $385M
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- 0.8
- P/S
- 0.3
- Yield
- —
- Per share
- —
- ▲Insiders net buying $284K over the last 3 months (6 open-market buys, 1 sale)
- 🏛Institutions accumulating (13F)
Auna S.A. (AUNA) is a Healthcare company listed on NYSE. The stock is down 18% over the past year. Over the trailing 3 months, insiders filed 6 open-market buys and 1 sale (SEC Form 4).
Auna S.A. (AUNA) financials & analyst ratings
Fundamentals (TTM)
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
AUNA earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 20, 2026 | $0.19 | $0.05 | -73.7% | $336M | +5.0% |
| Mar 11, 2026 | $0.20 | $0.53 | +169.3% | $337M | +1.2% |
| Nov 20, 2025 | $0.15 | $0.20 | +33.3% | $316M | -70.7% |
| Aug 19, 2025 | $0.13 | $0.33 | +153.8% | $308M | -73.7% |
| May 20, 2025 | $0.10 | $0.19 | +90.0% | $1.0B | -11.3% |
| Mar 10, 2025 | $0.15 | $0.12 | -20.0% | $1.1B | +264.5% |
| Nov 19, 2024 | $0.18 | $0.26 | +44.4% | $4.4B | +278.7% |
| Aug 21, 2024 | $0.15 | $0.03 | -80.0% | $4.4B | +1388.9% |
| May 22, 2024 | $0.14 | $0.10 | -28.6% | $1.1B | +287.7% |
| Dec 31, 2023 | — | $-4.54 | — | $1.0B | — |
| Sep 30, 2023 | — | $-0.94 | — | $1.0B | — |
| Jun 30, 2023 | — | $0.04 | — | $946M | — |
AUNA insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 1, 2026 | Zamora Leon Jesusdirector, officer: President | Buy | 5,814 | $4.39 |
| Jun 1, 2026 | Zamora Leon Jesusdirector, officer: President | Buy | 9,220 | $4.17 |
| Jun 1, 2026 | Wilton Johndirector | Sell | 17,574 | $4.17 |
| Jun 1, 2026 | Zamora Leon Jesusdirector, officer: President | Buy | 6,420 | $4.15 |
| Jun 1, 2026 | Zamora Leon Jesusdirector, officer: President | Buy | 30,000 | $4.39 |
| May 28, 2026 | Zamora Leon Jesusdirector, officer: President | Buy | 23,273 | $4.20 |
| May 28, 2026 | Zamora Leon Jesusdirector, officer: President | Buy | 8,727 | $4.24 |
Source: AUNA SEC Form 4 filings, latest Jun 1, 2026. For informational purposes only — not investment advice.
See the full AUNA insider & 13F page →Auna S.A. company profile
Overview
Auna SA (NYSE:AUNA) is a multinational healthcare service provider founded in 1989 and headquartered in Luxembourg. The company operates an integrated network of hospitals, clinics, and healthcare facilities across three Latin American markets: Peru, Mexico, and Colombia. Over its 35-year history, Auna has grown from a single facility to become one of the region's largest private healthcare operators, serving millions of patients through both direct medical services and prepaid health insurance plans. The company went public to expand its footprint and modernize healthcare infrastructure in underserved Latin American markets.
Business
Auna operates in the private healthcare services industry across Latin America, focusing on providing comprehensive medical care through an integrated model that combines healthcare facilities with insurance products. The company's core business revolves around two main segments that work synergistically to create a vertically integrated healthcare ecosystem. The primary segment is Healthcare Services, which encompasses the operation of hospitals, clinics, and specialized medical centers across Peru, Mexico, and Colombia. These facilities provide a full spectrum of medical services including emergency care, surgical procedures, diagnostic imaging, laboratory services, maternity care, and specialized treatments. The hospitals range from large tertiary care facilities capable of complex procedures to smaller community clinics that serve as primary care access points. This segment generates approximately 70-75% of total revenue based on recent financial performance. The secondary but strategically important segment is Health Insurance and Prepaid Plans, where Auna offers managed care products primarily in Peru and dental/vision plans in Mexico. These prepaid healthcare plans function similarly to health maintenance organizations (HMOs), where members pay monthly premiums in exchange for access to Auna's network of facilities and services. This insurance business creates a captive patient base that utilizes Auna's own medical facilities, generating both premium revenue and medical service fees. This segment accounts for roughly 25-30% of total revenue. The company's integrated model creates significant operational synergies, as the insurance plans drive patient volume to Auna's own facilities while the medical facilities provide the infrastructure needed to deliver on insurance commitments. This vertical integration is particularly valuable in Latin American markets where healthcare access and quality can be inconsistent.
Revenue model
Auna generates revenue through multiple complementary streams within its integrated healthcare model. The primary revenue source comes from direct medical services, where patients or their insurers pay for hospital stays, surgical procedures, diagnostic tests, emergency care, and outpatient services. These services are typically reimbursed through a combination of private insurance, government programs, and direct patient payments, with pricing varying significantly across the three countries of operation. The second major revenue stream derives from insurance premiums and prepaid plan subscriptions. Members pay monthly or annual fees for access to Auna's healthcare network, creating predictable recurring revenue. In Peru, these comprehensive health plans compete with both public healthcare options and other private insurers. In Mexico, the focus is more specialized on dental and vision coverage, which represents a growing market as middle-class consumers seek supplemental coverage beyond basic public healthcare. The company's paying customers include individual consumers purchasing insurance plans, employers providing health benefits to employees, government contracts for certain services, and direct-pay patients seeking private healthcare. The mix varies by country, with Peru showing stronger penetration of private insurance while Mexico and Colombia have higher proportions of direct-pay and employer-sponsored coverage. Several factors significantly impact Auna's margins and profitability. Currency fluctuations present ongoing challenges as the company reports in US dollars but operates primarily in local currencies (Peruvian sol, Mexican peso, Colombian peso), creating translation risk and affecting competitiveness. Regulatory changes in healthcare policy, insurance requirements, and medical pricing can dramatically impact both costs and reimbursement rates. Economic conditions in Latin America directly affect patients' ability to afford private healthcare and employers' willingness to provide comprehensive benefits. Medical inflation, including rising costs for pharmaceuticals, medical devices, and specialized equipment, pressures margins if not offset by corresponding price increases. Competition from both local healthcare providers and international chains entering these markets can compress pricing power, while physician and nursing shortages common in the region drive up labor costs and can limit capacity expansion.
Competitive moat
Auna's competitive moat is moderate and primarily built on geographic market presence and integrated care delivery, though it faces significant structural challenges common to healthcare providers in emerging markets. The company's strongest defensive characteristic is its established network effect in Peru, where its insurance plans create patient loyalty and drive utilization to its own facilities. This vertical integration provides some protection against pure-play competitors who must rely on external networks or compete solely on facility quality. The company benefits from regulatory barriers and licensing requirements that make healthcare facility development complex and time-consuming, particularly for international entrants unfamiliar with local medical regulations. Additionally, Auna has built relationships with medical professionals and developed local market knowledge that would be difficult for new competitors to replicate quickly. However, the moat is not particularly strong or durable. Healthcare is fundamentally a local business where patient preferences, physician relationships, and geographic convenience often outweigh brand loyalty. Large international healthcare companies with superior capital resources could potentially enter these markets and compete effectively, especially in major metropolitan areas. Government policy changes represent a constant threat, as Latin American countries frequently adjust healthcare regulations, insurance requirements, and public healthcare funding in ways that can dramatically alter competitive dynamics. The company also faces disruption risks from telemedicine and digital health platforms that can provide certain services more efficiently, particularly in markets with limited healthcare infrastructure. Economic volatility in Latin America creates cyclical pressures that can force patients to switch from private to public healthcare options during downturns, eroding the customer base regardless of service quality. Overall, while Auna has built a respectable market position, the moat is primarily operational rather than structural and could be challenged by well-capitalized competitors or significant regulatory shifts.
Risks & safety
Auna presents moderate financial risk with concerning liquidity metrics but reasonable debt management and improving operational performance. • Liquidity concerns: Current ratio of 0.88 indicates working capital challenges, with current liabilities exceeding current assets by approximately $64 million. Quick ratio of 0.80 shows limited liquid asset coverage. • Debt levels: Debt-to-equity ratio of 2.55 represents high leverage, though this has improved from 3.30 in 2022. Total debt burden appears manageable given healthcare industry norms and cash generation. • Cash position: $63 million in cash and short-term investments provides some cushion, though relatively modest given $520 million in current liabilities. • Cash generation: Positive free cash flow of $154 million for 2024 demonstrates strong operational cash conversion and ability to service debt obligations. • Valuation metrics: Trading at 15.9x earnings and 5.4x EV/EBITDA suggests reasonable valuation, though P/E ratio volatile due to earnings fluctuations. • Profitability recovery: Returned to profitability in 2024 ($29 million net income) after losses in 2022-2023, indicating operational turnaround progress. • Currency exposure: Significant exposure to Latin American currency fluctuations creates additional financial volatility beyond operational control.
Recent development
Based on the financial data trends, Auna has undergone significant operational transformation over the past few years, though detailed strategic initiatives are not available from earnings call transcripts. The most notable development has been the company's financial turnaround and profitability recovery. After posting substantial losses of $58 million in 2023 and $20 million in 2022, Auna returned to profitability in 2024 with $29 million in net income, demonstrating successful cost management and operational efficiency improvements. Revenue growth acceleration has been substantial, with total revenue increasing from $645 million in 2022 to $1.17 billion in 2024, representing an 82% increase over two years. This growth appears to be driven by both organic expansion and improved utilization rates across the company's healthcare network. The EBITDA improvement from $79 million in 2022 to $261 million in 2024 indicates strong operational leverage and margin expansion. Balance sheet strengthening has been another key focus area. The company reduced its debt-to-equity ratio from 3.30 in 2022 to 2.55 in 2024, while simultaneously improving cash flow generation. Free cash flow increased dramatically from just $3 million in 2022 to $154 million in 2024, providing greater financial flexibility for growth investments and debt reduction. The geographic expansion strategy appears to be bearing fruit, with the company successfully scaling operations across Peru, Mexico, and Colombia. The integrated model combining insurance products with healthcare facilities has shown resilience, particularly as Latin American markets recover from economic pressures and healthcare demand normalizes post-pandemic.
AUNA company profile · for informational purposes only — not investment advice.
Track AUNA with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free